XPhyto Signs Letter of Intent for US Manufacturing and Strategic Business Opportunities
VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / October 4, 2022 /XPhyto Therapeutics Corp. (CSE:XPHY)( OTCQB:XPHYF)(FSE:4XT) (“XPhyto” or the “Company”) is pleased to report that it has signed …